• EN
    • SV
  • About Us
    • Overview
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Commitment to diversity
    • Our history
  • Our Science
    • Overview
    • Ion channels
    • Publications/presentations
    • Partnerships & spinouts
    • The discovery process
  • Our Pipeline
    • Overview
    • Tesomet
    • SAN711
    • SAN903
    • SAN2219
    • The development process
  • Patients & Caregivers
    • Overview
    • Hypothalamic obesity
    • Prader-Willi syndrome
    • Rare diseases
    • Advocacy at Saniona
  • Investor Relations
    • Overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Overview
    • Press Releases
    • Voices
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
  • EN
  • SV
NEWSROOM

Voices

Saniona Icon blue
Saniona’s CEO comments on the collaboration with AstronauTx
July 18, 2023 | BioStock

ABOUT US

Vision, mission, values

Our strategy

Executive team

Board of directors

Commitment to diversity

Our history

OUR SCIENCE

Ion channels

Publications / presentations

Partnerships & spinouts

The discovery process

OUR PIPELINE

Tesomet

SAN711

SAN903

SAN2219

The development process

PATIENTS & CAREGIVERS

Hypothalamic obesity

Prader-Willi syndrome

Rare diseases

Advocacy at Saniona

INVESTORS

The share

Financial calendar

Financial reports and filings

Analyst coverage

Events and presentations

FAQs

Corporate Governance

NEWSROOM

Press releases

Voices

Media kit

 

JOIN US

Working with us

Current Openings

Saniona
DENMARK

Smedeland 26B
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2023 Saniona. All rights reserved.

Privacy Policy